1. Receptor for Advanced Glycation End Product, Organ Crosstalk, and Pathomechanism Targets for Comprehensive Molecular Therapeutics in Diabetic Ischemic Stroke
   Nivedita L. Rao et al, 2022, Biomolecules CrossRef
2. Circulating Soluble Receptor for Advanced Glycation End Products (sRAGE) as a Biomarker of Emphysema and the RAGE Axis in the Lung
   John G. Yonchuk et al, 2015, American Journal of Respiratory and Critical Care Medicine CrossRef
3. The Effects of Dietary Advanced Glycation End-Products on Neurocognitive and Mental Disorders
   Nathan M. D’Cunha et al, 2022, Nutrients CrossRef
4. Targeting High Mobility Group Box 1 in Subarachnoid Hemorrhage: A Systematic Review
   Sajjad Muhammad et al, 2020, International Journal of Molecular Sciences CrossRef
5. Soluble receptor for advanced glycation end-products promotes angiogenesis through activation of STAT3 in myocardial ischemia/reperfusion injury
   Xianxian Cao et al, 2020, Apoptosis CrossRef
6. The role of soluble receptor for advanced glycation end-products (sRAGE) in the general population and patients with diabetes mellitus with a focus on renal function and overall outcome
   Mieke Steenbeke et al, 2021, Critical Reviews in Clinical Laboratory Sciences CrossRef
7. P-selectin targeted RAGE-shRNA lipoplexes alleviate atherosclerosis-associated inflammation
   Cristina Ana Mocanu et al, 2021, Journal of Controlled Release CrossRef
8. Blood flow modulation of vascular dynamics
   Juhyun Lee et al, 2015, Current Opinion in Lipidology CrossRef
9. The role of advanced glycation end-products in the development of coronary artery disease in patients with and without diabetes mellitus: a review
   Sarah Louise Fishman et al, 2018, Molecular Medicine CrossRef
10. An update on the potential role of advanced glycation end products in glycolipid metabolism
    Xiaolei Wang et al, 2020, Life Sciences CrossRef
11. Coxsackievirus and adenovirus receptor mediates the responses of endothelial cells to fluid shear stress
    Jihwa Chung et al, 2019, Experimental & Molecular Medicine CrossRef
12. Cardiovascular Consequences of Uremic Metabolites: an Overview of the Involved Signaling Pathways
    Adelina Curaj et al, 2024, Circulation Research CrossRef
13. Ursodeoxycholic Acid (UDCA) Exerts Anti-Atherogenic Effects by Inhibiting RAGE Signaling in Diabetic Atherosclerosis
    Jihwa Chung et al, 2016, PLOS ONE CrossRef
14. Physiology and coronary artery disease: emerging insights from computed tomography imaging based computational modeling
    Parastou Eslami et al, 2020, The International Journal of Cardiovascular Imaging CrossRef
15. Blood and Tissue Advanced Glycation End Products as Determinants of Cardiometabolic Disorders Focusing on Human Studies
    Yoona Kim, 2023, Nutrients CrossRef
16. Advanced Glycation End Products: Potential Mechanism and Therapeutic Target in Cardiovascular Complications under Diabetes
    Ping Yang et al, 2019, Oxidative Medicine and Cellular Longevity CrossRef
17. Pathophysiological Mechanisms That Alter the Autonomic Brain-Liver Communication in Metabolic Diseases
    Anisia Silva et al, 2021, Endocrinology CrossRef
18. Relationship of Advanced Glycation End Products With Cardiovascular Disease in Menopausal Women
    Magdalena Pertynska-Marczewska et al, 2015, Reproductive Sciences CrossRef
19. Therapeutic effect of human ApoA‐I‐Milano variant in aged transgenic mouse model of Alzheimer's disease
    Montse Solé et al, 2023, British Journal of Pharmacology CrossRef
20. Complex interplay of multiple biological systems that contribute to post-stroke infections
    Raymond Shim et al, 2018, Brain, Behavior, and Immunity CrossRef
21. Soluble Receptor for Advanced Glycation End Product: A Biomarker for Acute Coronary Syndrome
    Louise J. N. Jensen et al, 2015, BioMed Research International CrossRef
22. Understanding the role of glycation in the pathology of various non-communicable diseases along with novel therapeutic strategies
    Nilima S Bangar et al, 2022, Glycobiology CrossRef